NATCO Pharma Limited (NATCOPHARM.BO)

999.35 +0.50 (+0.05%) At close: 12:49PM IST

NATCO Pharma Limited

NATCO House
Road No. 2 Banjara Hills
Hyderabad 500034
India
91 40 2354 7532
https://www.natcopharma.co.in

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 3,946

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Venkaiah Chowdary Nannapaneni M. Pharm, MS.	MD & Chairman	N/A	N/A	1945
Mr. Rajeev Nannapaneni	CEO & Vice Chairman	N/A	N/A	1977
Mr. S. V. V. N. Appa Rao	Chief Financial Officer	N/A	N/A	N/A
Dr. Donthineni Linga Rao M.D.	President of Technical Affairs & Whole Time Director	N/A	N/A	1952
Mr. Chekuri Venkat Ramesh C.S.	Company Secretary & Compliance Officer	3M	N/A	N/A
Mr. Potluri Sivaramakrishna Prasad	Executive VP of Corporate Engineering Services & Whole Time Director	N/A	N/A	1958
Dr. Pavan Ganapati Bhat	Executive VP of Technical Operations & Director	N/A	N/A	1967
Sanivarapu Raviprakash Reddy	Senior Vice President of Operations	N/A	N/A	N/A
N. Sadasiva Rao	Executive Vice President of Corporate Affairs, Legal, Secretarial & Estate Management	N/A	N/A	N/A
James Rajakumar	Vice President of Marketing & Sales - Domestic	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.

Description

NATCO Pharma Limited, a pharmaceutical company, develops, manufactures, and markets finished dosage formulations and active pharmaceutical ingredients (APIs). It offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, ovary, etc.; and APIs in various categories, such as oncology, central nervous system, pain management, and CV care. The company offers orthopedic products comprising bisphosphonates, which are oral and injectable drugs; and gastroenterology products consisting of novel drugs for chronic hepatitis-B and hepatitis-C, as well as contract manufacturing services. In addition, it provides cardiology and diabetology products for the treatment of hypertension, stable angina, and CHF. Further, the company offers agro chemicals and biological pest management solutions for management of insects, diseases, and weeds across a range of crops. It markets its products in approximately 50 countries. The company was incorporated in 1981 and is headquartered in Hyderabad, India.

Corporate governance

NATCO Pharma Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.